Wei Zuo

543 total citations
37 papers, 361 citations indexed

About

Wei Zuo is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Wei Zuo has authored 37 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 14 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Wei Zuo's work include Gallbladder and Bile Duct Disorders (4 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers) and MicroRNA in disease regulation (3 papers). Wei Zuo is often cited by papers focused on Gallbladder and Bile Duct Disorders (4 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers) and MicroRNA in disease regulation (3 papers). Wei Zuo collaborates with scholars based in China, United States and Slovenia. Wei Zuo's co-authors include Jinfang Hu, Wei Bai, Shuyun Chen, Fang Yan, Jian Cui, Junbo Hong, Zhiguo Zhang, Li Li, Lei Zhao and Fei Xu and has published in prestigious journals such as Journal of Clinical Oncology, Journal of neurosurgery and Journal of Cellular Physiology.

In The Last Decade

Wei Zuo

36 papers receiving 356 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei Zuo China 12 198 113 103 68 45 37 361
Jun Meng China 11 184 0.9× 75 0.7× 136 1.3× 115 1.7× 61 1.4× 23 392
Lin-ang Wang China 11 189 1.0× 76 0.7× 117 1.1× 111 1.6× 56 1.2× 17 356
Haifeng Wang China 10 153 0.8× 127 1.1× 62 0.6× 53 0.8× 98 2.2× 43 357
Ailing Zhong China 13 192 1.0× 59 0.5× 104 1.0× 124 1.8× 42 0.9× 29 355
Yuanjie Niu China 10 160 0.8× 146 1.3× 57 0.6× 50 0.7× 63 1.4× 22 342
Jingyu Zhu China 12 145 0.7× 138 1.2× 90 0.9× 47 0.7× 78 1.7× 36 345

Countries citing papers authored by Wei Zuo

Since Specialization
Citations

This map shows the geographic impact of Wei Zuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Zuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Zuo more than expected).

Fields of papers citing papers by Wei Zuo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Zuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Zuo. The network helps show where Wei Zuo may publish in the future.

Co-authorship network of co-authors of Wei Zuo

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Zuo. A scholar is included among the top collaborators of Wei Zuo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Zuo. Wei Zuo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Li, Pengtao, Xingyu Zhu, Xiaoyu Liu, et al.. (2025). Intranasal delivery of engineered extracellular vesicles promotes neurofunctional recovery in traumatic brain injury. Journal of Nanobiotechnology. 23(1). 229–229. 4 indexed citations
3.
Xu, Wentao, Jiajia Zheng, Li Sun, et al.. (2025). Intravesical delivery of mucoadhesive and tumor-selective-penetrating nanozymes for enhancing the PDT of bladder cancer. Journal of Nanobiotechnology. 23(1). 554–554. 1 indexed citations
4.
Cui, Jian, Fei Xu, Wei Bai, et al.. (2023). HDAC inhibitor ITF2357 reduces resistance of mutant-KRAS non-small cell lung cancer to pemetrexed through a HDAC2/miR-130a-3p-dependent mechanism. Journal of Translational Medicine. 21(1). 125–125. 11 indexed citations
5.
Huang, Fang, et al.. (2023). SLC12A8 mediates TKI resistance in EGFR-mutant lung cancer via PDK1/AKT axis. Journal of Cancer Research and Clinical Oncology. 149(18). 16729–16739. 4 indexed citations
6.
7.
Wang, Shijiang, Jiangbo Nie, Yang Liu, et al.. (2023). YY1 is regulated by ALKBH5-mediated m6A modification and promotes autophagy and cancer progression through targeting ATG4B. Aging. 15(18). 9590–9613. 11 indexed citations
8.
Hu, Jinfang, et al.. (2022). Loss of RAGE prevents chronic intermittent hypoxia-induced nonalcoholic fatty liver disease via blockade of NF-кB pathway. Gene Therapy. 30(3-4). 278–287. 7 indexed citations
9.
Zuo, Wei, Hui Yang, Nianshuang Li, et al.. (2022). Helicobacter pylori infection activates Wnt/β-catenin pathway to promote the occurrence of gastritis by upregulating ASCL1 and AQP5. Cell Death Discovery. 8(1). 257–257. 20 indexed citations
10.
Zuo, Wei, et al.. (2021). Risk factors for brain metastases from non-small-cell lung cancer. Medicine. 100(9). e24724–e24724. 13 indexed citations
11.
Hong, Junbo, Wei Zuo, Liang Zhu, et al.. (2020). Cannulation procedure optimization for patients with duodenal papillary tumors. Surgical Endoscopy. 35(10). 5635–5642. 1 indexed citations
12.
Zuo, Wei, et al.. (2020). Risk factors for depression in patients with chronic obstructive pulmonary disease. World Journal of Psychiatry. 10(4). 59–70. 15 indexed citations
13.
Hong, Junbo, Wei Zuo, Xiaodong Zhou, et al.. (2020). Bedside Biliary Drainage without Fluoroscopy for Critically Ill Patients. BioMed Research International. 2020(1). 2850540–2850540. 2 indexed citations
14.
15.
16.
Cui, Jian, Jun Wang, Chao Lin, Jixiang Liu, & Wei Zuo. (2019). <p>Osteopontin Mediates Cetuximab Resistance via the MAPK Pathway in NSCLC Cells</p>. OncoTargets and Therapy. Volume 12. 10177–10185. 8 indexed citations
17.
Hu, Jinfang, et al.. (2019). Inhibition of the PD-1/PD-L1 signaling pathway enhances innate immune response of alveolar macrophages to mycobacterium tuberculosis in mice. Pulmonary Pharmacology & Therapeutics. 60. 101842–101842. 20 indexed citations
18.
Hu, Jinfang, et al.. (2019). High expression of RAD51 promotes DNA damage repair and survival in KRAS-mutant lung cancer cells. BMB Reports. 52(2). 151–156. 39 indexed citations
19.
Wu, Zhihua, et al.. (2015). A study on the association of rs7950273 polymorphism in the PDGFD with ischaemic stroke in the Chinese Han population. Annals of Human Biology. 43(1). 78–80. 3 indexed citations
20.
Hong, Junbo, Liang Xia, Wei Zuo, et al.. (2014). Risk factors for intestinal metaplasia in concomitant gastric and duodenal ulcer disease. Experimental and Therapeutic Medicine. 7(4). 929–934. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jun Meng Breakdown of academic impact, for papers by Lin-ang Wang Breakdown of academic impact, for papers by Haifeng Wang Breakdown of academic impact, for papers by Ailing Zhong Breakdown of academic impact, for papers by Yuanjie Niu Breakdown of academic impact, for papers by Jingyu Zhu
Rankless by CCL
2026